Aarti Drugs Buyback 2019 Record Date, Buyback Price & Details

Aarti Drugs Limited (ADL) established in 1984. They are manufacturer of Pharmaceuticals products. Aarti Drugs has strong presence in the Anti-diarrhea, Anti-inflammatory therapeutic groups. The company has their manufacturing facilities at Tarapur and Sarigam. They manufactures Vitamins, Anti-arthritis, Anti-fungal, Antibiotics, ACE inhibitors, besides its range in , anti-diabetic, anti-cholinergic, sedatives and anti-depressant drugs. Their manufacturing units are GMP certified and under process of acquiring an ISO 9002 compliance for all its units and one of the units has already been approved.

Aarti Drugs Buy Back 2019 Offer Details:

Buyback Record Date:	29-Mar-2019
Board Meeting Approval:	15-Mar-2019
Public Announcement:	15-Mar-2019
Buyback Offer:	Rs.25.389 Crore
Buyback Offer Size:	5.29%
Number of Shares:	282100
Share Face Value:	Rs.10
Buyback Price:	Rs.900
Buyback Type:	–

Aarti Drugs buyback of 282100 equity shares which is around 5.29% of all the existing number of equity shares at a price of Rs.900 per equity share. The buyback offer not exceeding of Rs.25.389 crore of total buyback offer size.

Aarti Drugs Buyback Eligible Share Holders:
The investors are eligible of the buyback scheme who have Aarti Drugs shares in their Demat account as record date 29-March-2019. Investors can participate in the Aarti Drugs Buyback 2019 scheme as per the opening form by selling your shares. The payment will be given as per the accepted shares by the company under the Aarti Drugs buyback scheme.

Checkout Current Aarti Drugs Shares market price on NSE and BSE: Aarti Drugs Live Quote

Note: If anything you want to know about the buyback offer you can refer the Aarti Drugs buyback offer documents.